Mason Street Advisors’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,813
Closed -$520K 750
2020
Q4
$520K Sell
1,813
-6
-0.3% -$1.65K 0.01% 1158
2020
Q3
$463K Buy
1,819
+300
+20% +$71.3K 0.01% 1106
2020
Q2
$329K Buy
1,519
+120
+9% +$27.7K 0.01% 1207
2020
Q1
$316K Hold
1,399
0.01% 1138
2019
Q4
$349K Buy
1,399
+39
+3% +$9.13K 0.01% 1238
2019
Q3
$323K Buy
1,360
+178
+15% +$41.1K 0.01% 1244
2019
Q2
$289K Buy
+1,182
New +$275K 0.01% 1264

Other funds holding MLAB

Mason Street Advisors's MLAB Position: Q1 2021 in Review

Mason Street Advisors sold out of Mesa Laboratories (MLAB) in Q1 2021, closing a stake of 1,813 shares — an estimated $520K sold.

Mason Street Advisors first reported a position in MLAB in Q2 2019 and held it in 7 quarters. The position peaked at $520K in Q4 2020. 173 funds tracked by Wall St. Rank hold MLAB as of Q1 2021.

  • Mason Street Advisors reported no remaining Mesa Laboratories position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 1,813 Mesa Laboratories shares in Q1 2021, an estimated $520K.
  • Mason Street Advisors first reported a position in Mesa Laboratories in Q2 2019 and held it in 7 quarters.
  • Mason Street Advisors's Mesa Laboratories position peaked at $520K in Q4 2020.
  • 173 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.